CPhI logo
  • Products
  • Suppliers
  • Sourcing Requests
  • 中文站
  • Sign in     Join free
Post Sourcing Request Exhibition
  • Home
  • Products
  • Suppliers
  • EZSourcing
  • Industry Insights
  • Events
  • For Suppliers

    My Account

    My Online Store

    My EZSourcing

    View Sourcing Requests

    Customer Service

  • For Buyer

    Search Products & Suppliers

    Products Directory Suppliers Discovery Post EZSourcing

    Service

    Buyer Sourcing Event Contact Us

    Quick links

    My Favorites Recent Visit History
  • Market News
  • Industry Data
  • Features
  • Products Guide
  • Brand Story
You are here:   Industry Insights > Industry Data

Industry Data

  • Breaking News! Chia Tai Tianqing to Receive Approval for another Generic in China Industry Data CaicaiMarch 26, 2021
    The marketing application (acceptance No.: CYHS1900381) of Chia Tai Tianqing’s Class 4 generic drug has recently changed to the “Under approval” status, and the drug is expected to be approved for marketing this month ...
  • A Review of the Export Data of China’s Plant Extract Market in 2020 and Potential Varieties Industry Data PharmaSources.comMarch 18, 2021
    In 2020, the outbreak of the pandemic stimulated consumer demand for naturally sourced plant extracts, however, China’s export value of plant extracts in the first half of 2020 reached USD1.265 billion, up only 1.08% year on year.
  • Plant Extract Varieties with Great Market Potential Industry Data PharmaSources.comMarch 12, 2021
    The following plant extract varieties is considered to have great potential after summarizing various buying information and the sales of plant extracts in the U.S. market last year.
  • Junshi’s Anti-PD-1 Drug Achieved Sales of RMB1.3 Billion in 2020 Industry Data CaicaiMarch 12, 2021
    Junshi Biosciences has recently announced its 2020 annual performance preview, according to which, it achieved operating income of RMB1.595 billion, up 105.77% year on year, mainly thanks to the sales revenue growth of its anti-PD-1 drug.
  • Advantages to Drug Companies to Approach Continuous Manufacturing Industry Data Deepak HegdeMarch 11, 2021
    Learning what are the features attracting big pharma and generic companies to approach Continuous Manufacturing process from Batch Manufacturing process by reading Dr. Deepak Hegde's Continuous Manufacturing series articles.
  • Neutralizing Antibodies, the “Specific Drugs” against SARS-CoV-2 Industry Data YefenghongMarch 04, 2021
    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed into a global pandemic and become a serious public health and socioeconomic burden, and thus there is an urgent need for effective means of control.
  • Qilu Pharmaceutical Achieved Staggering Sales of Bevacizumab of RMB1.8 Billion in 2020 Industry Data CaicaiMarch 04, 2021
    According to industry news, Qilu Pharmaceutical achieved sales of bevacizumab (trade name: Ankeda) of about RMB1.8 billion in 2020.
  • Analysis of the Export Market of Gelatin and Its Derivatives Industry Data Chen ShipengFebruary 19, 2021
    Gelatin is a product made from animal bones, skins, muscles, tendons and scales after moderate hydrolysis (acid process, alkaline process, acid/alkaline process or enzymic method) and purification.
  • Enzymatic Synthesis of NMN: Greener and More Efficient Industry Data YuntianFebruary 19, 2021
    NMN, i.e., nicotinamide mononucleotide (Fig. 1), is a reaction product of nicotinamide phosphoribosyltransferase (NAMPT).
  • A Review of Chinese-produced Class 1 New Drugs from 2018 to 2020 Industry Data CaicaiJanuary 28, 2021
    From 2018 to 2020, the marketing of Chinese-produced Class 1 new drugs entered the harvest period, with a total of 32 marketed (Chinese-produced Class 1 new drugs here refer to drugs registered under the classification of chemical drugs 1 and therapeutic.
Previous page 1 2 3 4 5 6 7 8 ... 23 24 Next page

Contact Us

PharmaSources@imsinoexpo.com

Mon-Fri 9:00-18:00 UTC+8

Tel: (+86) 400 610 1188

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPhI China
P-MEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
  • Copyright 2006-2020 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
  • Links:
    CCCMHPIE SJGLE.com JJGLE.COM JDGLE.COM XIUGLE.COM DENGGLE.COM HPGLE.COM
  • Follow Us:

  • CPhI logo Pharma Sources Insight 01/2021